Pharma TechOps 2017, swiss pharma.#Swiss #pharma


Posted On Mar 4 2018 by

FROM A FIRE FIGHTER MENTALITY TO A FORMULA 1 SPIRIT

November 30 December 01, 2017 | Maritim proArte Hotel Berlin, Germany

The Pharma TechOps Sessions

The 2.5-day event is a unique combination of

Inspirational keynotes Panel discussions

Well moderated, interactive World Caf sessions

Challenge Your Peers roundtables

Be part of our exclusive platform to explore various business models, case studies actions to increase profitability and identify missing gaps that hide opportunities business chances for your challenges.

The 2.5-day event is a unique combination of

Inspirational keynotes Panel discussions

Well moderated, interactive World Caf sessions

Challenge Your Peers roundtables

Be part of our exclusive platform to explore various business models, case studies actions to increase profitability and identify missing gaps that hide opportunities business chances for your challenges.

Hundreds of maintenance & engineering projects and technology budgets under the same roof

Get involved at the event as a Business Partner. For our event partners it is a one-stop-shop opportunity to promote thought-leadership and get face-to-face with over 100 key prospects.

Pharma TechOps offers the best in class opportunity to introduce yourself as a thought leader to pharma professionals involved in maintenance and plant availability projects.

Get involved at the event as a Business Partner. For our event partners it is a one-stop-shop opportunity to promote thought-leadership and get face-to-face with over 100 key prospects.

Pharma TechOps offers the best in class opportunity to introduce yourself as a thought leader to pharma professionals involved in maintenance and plant availability projects.

Highlight Speakers 2017

Swiss pharma

Swiss pharma

Head of Global Manufacturing

The Grünenthal Group

Swiss pharma

Swiss pharma

Dr. Dieter Peters, Head of Global Manufacturing, The Grünenthal Group

Dieter Peters, born 1956, received his PHD at the University of Dortmund in chemistry. From 1986 to 1996 he worked at Hoechst AG and from 1996 to 2002 at Celanese AG. In 2002 he joined the Gr nenthal Group Switzerland as Managing Director. From October 2011 to May 2017 he worked as Head of Global Product Supply and since May 2017 he is the Head of Global Manufacturing. He is an expert in turn arounds and restructuring.

Challenge Your Peers

Operational Excellence in Pharma Manufacturing Technology, Capacity and Availability management in manufacturing can provide significant advantages to business – HOW?

  • How can pharma catch up with state of the art management processes, employee involvement and continuous improvement culture that are daily routine in other industries? (Deliverables: Key must haves to accomplish that)
  • What are you doing in your company to catch up and which benefits have you realized? (Deliverables: Changes you have implemented and your measurable business advantages)
  • What are you doing to discover the true waste in your processes and become more productive and service oriented? (Deliverables: What barriers did you overcome, what did you find which wasn t so obvious, what are your most memorable wins)
  • How do you work with regulatory requirements and departments to realize innovation and mitigate risk? (Deliverables: Examples of change and cooperation with regulatory colleagues to make it happen)
  • Who is driving innovation and change in your company what is your role? (Deliverable: Examples to make an Innovation out of an invention)
  • How do you efficiently connect R D and Manufacturing? (Deliverables: Example processes and Best Practice process)
  • How do you integrate external manufacturing in established and innovative products manufacturing? (Deliverables: Role model examples and lessons learned from challenged cooperation)

The Gr nenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation.

Our ambition is to deliver four to five new products to patients in diseases with high unmet medical need by 2022 and become a 2 billion company.

We are a fully integrated research development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in our R D above the industrial average, we are strongly committed to innovation.

Gr nenthal is an independent, family-owned company headquartered in Aachen, Germany. We are present in 32 countries with affiliates in Europe, Latin America and the US. Our products are sold in more than 155 countries and approx. 5,500 employees are working for the Gr nenthal Group worldwide. In 2016, Gr nenthal achieved revenues of approx. 1.4 bn.


Last Updated on: March 4th, 2018 at 10:19 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *